Search Results 981-990 of 17188 for ibd

1. A Study to Test the Addition of Nivolumab to Chemotherapy to Treat Soft Tissue Sarcoma - Mayo Clinic

   ... inflammatory bowel disease (IBD), Crohn's, ulcerative colitis, hepatitis; and patients with a history of toxic epidermal necrolysis (TEN), Stevens-Johnson ...

2. A Study to Evaluate Preoperative Oral Microbiota-Based Investigational New Drug to Target Immune Response in Patients with Operable Stage I-III Breast Cancer - Mayo Clinic

   History of inflammatory bowel disease (IBD); e.g., ulcerative colitis, Crohn's disease, or microscopic colitis. Diagnosis of irritable bowel syndrome (IBS) ...

3. Colon Cleansing: Mayo Clinic Radio Health Minute

   IBD Pride Clinic: Belonging while battling bowel disease · About the News Network · Newsbureau@mayo.edu · News Releases · Cancer · Cardiovascular ...

4. Justin T. Brady, M.D. - Doctors and Medical Staff - Mayo Clinic

   Brady, M.D., is a Colon and Rectal surgeon with expertise in organ preservation for rectal cancer. He is also an Assistant Professor of Medicine at the Mayo ...

5. NST-6179 in Adult Subjects with Intestinal Failure-Associated Liver Disease - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

6. Metabolic Dysfunction-Associated Steatotic Liver Disease Altered Fructose Absorption - Mayo Clinic

   Patients with a history of malabsorptive disease such as celiac disease or inflammatory bowel disease. Patients taking medications known to cause hepatic ...

7. Gastroenteritis: First aid - Mayo Clinic

   Gastroenteritis is an inflammation of the stomach and intestines that can cause watery diarrhea, nausea and vomiting. Gastroenteritis is often called the " ...

8. Vancomycin for Primary Sclerosing Cholangitis - Mayo Clinic

   PSC with or without inflammatory bowel disease, such as ulcerative colitis or Crohn's disease 8. Must agree to comply with the study protocol and provide ...

9. A Study to Evaluate Food on Gastrointestinal Toxicity and The Effect of Selumetinib in Adolescents with Neurofibromatosis Type 1 - Mayo Clinic

   Have refractory nausea and vomiting, chronic GI diseases (e.g., inflammatory bowel disease), or significant bowel resection that would adversely affect the ...

10. Gut and Tumor Microbiome in Patients With Advanced ER-positive and HER2-negative Breast Cancer or Advanced Melanoma Undergoing PD-1 Checkpoint Inhibitor Therapy. - Mayo Clinic

    History of inflammatory bowel disease, chronic diarrhea or malabsorption syndromes, or significant prior bowel resection as judged by the study investigator